Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).

Clin Rheumatol

Osteo-Articular Department, Rheumatic Disease and Internal Medicine Unit, Hospital and University of Parma,Via Gramsci, 14,43100 Parma, Italy.

Published: January 2007

Psoriatic onycho-pachydermo-periostitis (POPP)is a rare subset of psoriatic arthritis, characterized by onychopathy, painful thickening of the periungual soft tissues, and radiological features consisting of an exuberant periosteal reaction of the terminal phalanx. The POPP treatment is debated, and side effect risk of therapies may not be offset by their benefits. We report on a successful treatment with carnitine in a 15-year old boy suffering from POPP.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-006-0322-2DOI Listing

Publication Analysis

Top Keywords

psoriatic onycho-pachydermo-periostitis
8
carnitine therapeutic
4
therapeutic option
4
option childhood
4
childhood psoriatic
4
onycho-pachydermo-periostitis popp
4
popp psoriatic
4
onycho-pachydermo-periostitis poppis
4
poppis rare
4
rare subset
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!